Bio-Rad Laboratories Inc.

BIO | NYSE

Price Alert Chart Builder DCF Calculator

$376.62

+$0.21 (+0.06%)

Sep 21, 2026, 10:28 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $10.13B

Enterprise Value $9.72B

Beta 1.07

Average Volume 353.29K

Shares Outstanding (Diluted) 26.81M

Shares Change YoY -1.52%

Institutional Ownership 74.14%

Exchange NYSE

ISIN US0905722072

Price Performance

Price Change 1M 10.5%

Price Change 3M 33.9%

Price Change 6M 42.0%

Price Change YTD 23.3%

Price Change 1Y 31.4%

Price Change 3Y 6.6%

Price Change 5Y -53.1%

1M CAGR (ann.) 9.9%

1Y CAGR (ann.) 34.3%

5Y CAGR (ann.) -14.4%

All-Time CAGR 8.7%

Valuation

PE Ratio 45.63

Forward PE 35.91

PEG Ratio -0.15

Forward PEG 6.16

PS Ratio 3.91

Forward PS 3.80

PB Ratio 1.41

P/FCF Ratio 28.69

P/Adj. FCF Ratio 32.97

P/OCF Ratio 20.43

EV/Sales 3.75

EV/EBIT 25.10

EV/EBITDA 18.18

EV/FCF 27.52

Earnings Yield 2.2%

FCF Yield 3.5%

Adj. FCF Yield 3.0%

Financial Health

Net Cash $414.8M

Total Debt $1.2B

Cash & Short-Term Investments $1.62B

Total Assets $10.25B

Current Ratio 3.14

Quick Ratio 2.33

Debt / Equity Ratio 0.17

Debt / EBITDA 2.25

Debt / FCF 3.41

OCF / Debt 0.41

Interest Coverage 6.40

Altman Z-Score 3.69

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 51.9%

Operating Profit Margin 9.1%

EBITDA Margin 20.6%

Net Profit Margin 8.6%

FCF Margin 13.6%

Adj. FCF Margin 11.9%

SBC / Revenue 1.8%

SBC Impact (per share) -13.0%

Returns

Return on Assets 2.2%

Return on Equity 3.1%

Return on Invested Capital 1.5%

Return on Capital Employed 2.5%

Return on Tangible Assets 2.3%

Historical Growth (CAGR)

Revenue CAGR 3Y -2.2%

Revenue CAGR 5Y -2.1%

Revenue CAGR 10Y 2.5%

EPS CAGR 3Y 306.5%

EPS CAGR 5Y -42.8%

EPS CAGR 10Y 9.6%

FCF CAGR 3Y 32.2%

FCF CAGR 5Y -9.7%

FCF CAGR 10Y 16.3%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 14.2%

Revenue Growth Next 3Y 2.9%

Earnings Date Oct 28, 2026

EPS Estimate (next Q) $2.23

EPS Growth Est (next Q) -1.3%

Revenue Est (next Q) $650.64M

Revenue Growth Est (next Q) -0.4%

Fair Value Estimates

Graham Number $223.13

Graham Upside -40.7%

Lynch Fair Value $41.25

Lynch Upside -89.0%

Price Target $350

Price Target Upside -7.0%

Cash Flow

Operating Cash Flow $492.6M

Free Cash Flow $353.1M

Adj. Free Cash Flow $307.3M

FCF Per Share $13.20

OCF Per Share $18.42

OCF/S Ratio 19.0%

Income Statement

Revenue $2.59B

Gross Profit $1.34B

Operating Income $235M

EBITDA $534.6M

Net Income $222.4M

EPS (Diluted) $8.25

Revenue / Employee $347.56K

Profit / Employee $29.85K

Employees 7,450